Pharmacology
 |
|
21 november 2020 14:21:22 |
| How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine (Drug Safety) |
|
Tweet |
| 396 viewsCategory: Pharmacology |
 [ASAP] Mitochondria-Targeted Polyamidoamine Dendrimer–Curcumin Construct for Hepatocellular Cancer Treatment (Molecular Pharmaceutics)Current Evidence on Abuse and Misuse of Gabapentinoids (Drug Safety) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
